Are Improvements in Measured Performance Driven by Better Treatment or 'Denominator Management'?

MLA

Anna D. Rubinsky, et al. “Are Improvements in Measured Performance Driven by Better Treatment or ‘Denominator Management’?” Journal of General Internal Medicine, vol. 31, Mar. 2016, pp. 21–27. EBSCOhost, https://doi.org/10.1007/s11606-015-3558-1.

APA

Anna D. Rubinsky, Matthew Neuman, Katherine J. Hoggatt, Megan E. Vanneman, Cheng Chen, & Alex H. S. Harris. (2016). Are Improvements in Measured Performance Driven by Better Treatment or “Denominator Management”? Journal of General Internal Medicine, 31, 21–27. https://doi.org/10.1007/s11606-015-3558-1

Chicago

Anna D. Rubinsky, Matthew Neuman, Katherine J. Hoggatt, Megan E. Vanneman, Cheng Chen, and Alex H. S. Harris. 2016. “Are Improvements in Measured Performance Driven by Better Treatment or ‘Denominator Management’?” Journal of General Internal Medicine 31 (March): 21–27. doi:10.1007/s11606-015-3558-1.